[go: up one dir, main page]

SE9001592D0 - A therapeutical composition - Google Patents

A therapeutical composition

Info

Publication number
SE9001592D0
SE9001592D0 SE9001592A SE9001592A SE9001592D0 SE 9001592 D0 SE9001592 D0 SE 9001592D0 SE 9001592 A SE9001592 A SE 9001592A SE 9001592 A SE9001592 A SE 9001592A SE 9001592 D0 SE9001592 D0 SE 9001592D0
Authority
SE
Sweden
Prior art keywords
pct
date nov
composition
hydrolyzed
sec
Prior art date
Application number
SE9001592A
Other languages
English (en)
Other versions
SE469209B (sv
SE9001592L (sv
Inventor
Anthony De Belder
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9001592A priority Critical patent/SE469209B/sv
Publication of SE9001592D0 publication Critical patent/SE9001592D0/sv
Priority to CA002082060A priority patent/CA2082060A1/en
Priority to AU78617/91A priority patent/AU648556B2/en
Priority to PCT/SE1991/000317 priority patent/WO1991016906A1/en
Priority to EP91909186A priority patent/EP0532524A1/en
Priority to US07/941,119 priority patent/US5324717A/en
Publication of SE9001592L publication Critical patent/SE9001592L/sv
Publication of SE469209B publication Critical patent/SE469209B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9001592A 1990-05-04 1990-05-04 Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa SE469209B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9001592A SE469209B (sv) 1990-05-04 1990-05-04 Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa
CA002082060A CA2082060A1 (en) 1990-05-04 1991-05-03 Therapeutical composition
AU78617/91A AU648556B2 (en) 1990-05-04 1991-05-03 Therapeutic composition containing hydrolysed carboxyalkyl cellulose
PCT/SE1991/000317 WO1991016906A1 (en) 1990-05-04 1991-05-03 A therapeutical composition
EP91909186A EP0532524A1 (en) 1990-05-04 1991-05-03 A therapeutical composition
US07/941,119 US5324717A (en) 1990-05-04 1991-05-03 Therapeutical composition comprising hydrolyzed carboxylalkyl cellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001592A SE469209B (sv) 1990-05-04 1990-05-04 Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa

Publications (3)

Publication Number Publication Date
SE9001592D0 true SE9001592D0 (sv) 1990-05-04
SE9001592L SE9001592L (sv) 1991-11-05
SE469209B SE469209B (sv) 1993-06-07

Family

ID=20379372

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001592A SE469209B (sv) 1990-05-04 1990-05-04 Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa

Country Status (6)

Country Link
US (1) US5324717A (sv)
EP (1) EP0532524A1 (sv)
AU (1) AU648556B2 (sv)
CA (1) CA2082060A1 (sv)
SE (1) SE469209B (sv)
WO (1) WO1991016906A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266334A (en) * 1992-07-29 1993-11-30 Merrell Dow Pharmaceuticals Inc. Sugar-free dry mix cellulose ether compositions as bulk laxatives
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
JPS6094401A (ja) * 1983-10-31 1985-05-27 Asahi Chem Ind Co Ltd 吸液特性のすぐれたセルロース誘導体およびその製造方法
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions

Also Published As

Publication number Publication date
SE469209B (sv) 1993-06-07
AU7861791A (en) 1991-11-27
WO1991016906A1 (en) 1991-11-14
CA2082060A1 (en) 1991-11-05
US5324717A (en) 1994-06-28
AU648556B2 (en) 1994-04-28
EP0532524A1 (en) 1993-03-24
SE9001592L (sv) 1991-11-05

Similar Documents

Publication Publication Date Title
ATE198149T1 (de) Verfahren zur stabilisierung von duocarmycinderivaten
DE69418461D1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
SE9504661D0 (sv) New compounds
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
BR9407239A (pt) Azadioxacicloalquenos substituídos
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
NO994248D0 (no) Startkit omfattende nikotinsyresammensetninger
HU9301452D0 (en) Amino-pyrimidine derivatives of insecticidal, acaricidal and fungicidal effects
FI945081A0 (sv) Stabilt hydratiserat cefalosporintorrpulver för oral suspensionsformulering
DK0874812T3 (da) Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf
DE59507755D1 (de) Dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten
BR9509975A (pt) Formulação farmacêutica
FR2639225B1 (fr) Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
SE9001592D0 (sv) A therapeutical composition
DK67384A (da) N-iminopyridiniumbetainderivater
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
ES8600196A1 (es) Un procedimiento para preparar derivados de biciclooctano
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
FR2756562B1 (fr) Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FI925444A0 (fi) Utgaongsaemnen foer framstaellning av 10b-h-steroider och framstaellning avdessa utgaongsaemnen
SE9501512D0 (sv) Synthetic peptide-defined eptopes useful for vaccination against papillomavirus

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9001592-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 9001592-6

Format of ref document f/p: F